Invasive Subacute Pulmonary Aspergillosis After Puerperal Sepsis: Case Report

Killen H Briones-Claudett1,2,3, Mónica H Briones-Claudett2,3, Roger Alexander Murillo Vasconez2

  • 1Universidad de Guayaquil, Guayaquil, Ecuador.

Insights

Subacute invasive aspergillosis, a serious lung infection, was diagnosed in a post-sepsis patient using bronchoscopy. Early detection and treatment with voriconazole led to a favorable outcome, highlighting the importance of timely intervention.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Mycology

Background:

  • Subacute invasive aspergillosis is a destructive lung infection affecting immunocompromised individuals.
  • Early diagnosis and treatment are crucial for improving patient outcomes.

Observation:

  • A 19-year-old woman with puerperal sepsis developed left lung atelectasis and hemodynamic instability.
  • Imaging revealed round opacities, leading to flexible bronchoscopy with bronchoalveolar lavage.
  • Bronchoscopy confirmed Aspergillus implantation, supported by positive culture and serum galactomannan.

Findings:

  • Flexible bronchoscopy with bronchoalveolar lavage enabled direct visualization and sampling.
  • Aspergillus was identified in bronchoalveolar lavage cultures.
  • Serum galactomannan antigen test was positive, aiding diagnosis.

Implications:

  • Subacute invasive aspergillosis is a severe infection with potentially high mortality.
  • Bronchoscopy is an effective tool for diagnosing invasive aspergillosis in the lungs.
  • Prompt treatment with antifungal agents like voriconazole can lead to clinical improvement.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
551
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
640
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
596
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
785
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
534